<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1161" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1161/" /><meta name="ncbi_pagename" content="Alzheimer Disease Overview - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Alzheimer Disease Overview - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Alzheimer Disease Overview" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/12/20" /><meta name="citation_author" content="Thomas D Bird" /><meta name="citation_pmid" content="20301340" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1161/" /><meta name="citation_keywords" content="Early-Onset Familial Alzheimer Disease" /><meta name="citation_keywords" content="Late-Onset Familial Alzheimer Disease" /><meta name="citation_keywords" content="Amyloid-beta precursor protein" /><meta name="citation_keywords" content="Apolipoprotein E" /><meta name="citation_keywords" content="Presenilin-1" /><meta name="citation_keywords" content="Presenilin-2" /><meta name="citation_keywords" content="APOE" /><meta name="citation_keywords" content="APP" /><meta name="citation_keywords" content="PSEN1" /><meta name="citation_keywords" content="PSEN2" /><meta name="citation_keywords" content="Alzheimer Disease" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Alzheimer Disease Overview" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Thomas D Bird" /><meta name="DC.Date" content="2018/12/20" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1161/" /><meta name="description" content="The purpose of this overview is to increase the awareness of clinicians regarding Alzheimer disease (AD) and its genetic causes and management." /><meta name="og:title" content="Alzheimer Disease Overview" /><meta name="og:type" content="book" /><meta name="og:description" content="The purpose of this overview is to increase the awareness of clinicians regarding Alzheimer disease (AD) and its genetic causes and management." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1161/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/alzheimer/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1161/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AF2D1E040FC010000000004300198.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1161_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1161_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/alstrom/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/amish-mcph/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1161_"><span class="title" itemprop="name">Alzheimer Disease Overview</span></h1><p class="contrib-group"><span itemprop="author">Thomas D Bird</span>.</p><a data-jig="ncbitoggler" href="#__NBK1161_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1161_ai__"><div class="contrib half_rhythm"><span itemprop="author">Thomas D Bird</span><div class="affiliation small">Seattle VA Medical Center<br />Departments of Neurology and Medicine<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@zornmot" class="oemail">ude.wu@zornmot</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 23, 1998</span>; Last Update: <span itemprop="dateModified">December 20, 2018</span>.</p><p><em>Estimated reading time: 15 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="alzheimer.Summary" itemprop="description"><h2 id="_alzheimer_Summary_">Summary</h2><p>The purpose of this overview is to increase the awareness of clinicians regarding Alzheimer disease (AD) and its genetic causes and management.</p><p>The following are the goals of this overview.</p><div><h4 class="inline">Goal 1.</h4><p>Describe the <a href="#alzheimer._escape__1_Clinical_Characteri">clinical characteristics</a> of AD.</p></div><div><h4 class="inline">Goal 2.</h4><p>Review the genetic <a href="#alzheimer._escape__2_Causes_of_Alzheimer">causes</a> of AD.</p></div><div><h4 class="inline">Goal 3.</h4><p>Provide an <a href="#alzheimer._escape__3_Evaluation_Strategi">evaluation strategy</a> to identify the genetic cause of AD in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (when possible).</p></div><div><h4 class="inline">Goal 4.</h4><p>Inform <a href="#alzheimer._escape__4_Inform_Genetic_Coun">genetic counseling</a> of family members of an individual with AD.</p></div></div><div id="alzheimer._escape__1_Clinical_Characteri"><h2 id="_alzheimer__escape__1_Clinical_Characteri_">1. Clinical Characteristics of Alzheimer Disease</h2><p>Alzheimer disease (AD) is characterized by dementia that typically begins with subtle and poorly recognized failure of memory (often called mild cognitive impairment or MCI) and slowly becomes more severe and, eventually, incapacitating. Other common findings include confusion, poor judgment, language disturbance, visual complaints, agitation, withdrawal, and hallucinations. Occasionally, seizures, Parkinsonian features, increased muscle tone, myoclonus, incontinence, and mutism occur. Death usually results from general inanition, malnutrition, and pneumonia. The typical clinical duration of the disease is eight to ten years, with a range from one to 25 years.</p><p>Approximately 95% of all AD is late onset (age &#x0003e;60-65 years) and 5% is early onset (age &#x0003c;60-65 years).</p><p>Establishing the diagnosis of Alzheimer disease relies on clinical-neuropathologic assessment. Neuropathologic findings of &#x003b2;-amyloid plaques, intraneuronal neurofibrillary tangles (containing tau protein), and amyloid angiopathy remain the gold standard for diagnosis.</p><ul><li class="half_rhythm"><div>The plaques should stain positively with &#x003b2;-amyloid antibodies and negative for prion antibodies (which are diagnostic of <a href="/books/n/gene/prion/">prion diseases</a>).</div></li><li class="half_rhythm"><div>The numbers of plaques and tangles must exceed those found in age-matched controls without dementia. Guidelines for the quantitative assessment of these changes exist [<a class="bk_pop" href="#alzheimer.REF.montine.2012.1">Montine et al 2012</a>].</div></li><li class="half_rhythm"><div>Aggregation of alpha-synuclein in the form of Lewy bodies may also be found in neurons in the amygdala; frequently there is accumulation of TDP-43 protein [<a class="bk_pop" href="#alzheimer.REF.james.2016.2983">James et al 2016</a>, <a class="bk_pop" href="#alzheimer.REF.lemstra.2017.113">Lemstra et al 2017</a>].</div></li></ul><p>The clinical diagnosis of AD, based on clinical signs of slowly progressive dementia and neuroimaging findings of gross cerebral cortical atrophy, is correct approximately 80%-90% of the time. Greater precision can be obtained by use of more sophisticated studies such as amyloid PET imaging, CSF concentrations of amyloid and tau, and (in the near future) tau PET imaging and plasma concentration of &#x003b2; amyloid [<a class="bk_pop" href="#alzheimer.REF.dubois.2014.614">Dubois et al 2014</a>, <a class="bk_pop" href="#alzheimer.REF.gabelle.2015.672">Gabelle et al 2015</a>, <a class="bk_pop" href="#alzheimer.REF.sutphen.2015.1029">Sutphen et al 2015</a>, <a class="bk_pop" href="#alzheimer.REF.mattsson.2018.e388">Mattsson et al 2018</a>].</p><p><b>Differential diagnosis of Alzheimer disease</b> includes the following:</p><ul><li class="half_rhythm"><div><b>Treatable forms of cognitive decline</b> including depression, chronic drug intoxication, chronic CNS infection, thyroid disease, vitamin deficiencies (especially B<sub>12</sub> and thiamine), CNS angiitis, and normal-pressure hydrocephalus [<a class="bk_pop" href="#alzheimer.REF.bird.2008">Bird &#x00026; Miller 2008</a>]. CT and MRI can identify some of these other causes of dementia, including neoplasms, normal-pressure hydrocephalus, and cerebral vascular disease.</div></li><li class="half_rhythm"><div><b>Other degenerative disorders associated with dementia,</b> such as frontotemporal dementia (including frontotemporal dementia with parkinsonism-17; FTDP-17), Picks disease, <a href="/books/n/gene/parkinson-overview/">Parkinson disease</a>, diffuse Lewy body disease (LBD), <a href="/books/n/gene/prion/">Creutzfeldt-Jakob disease</a>, and <a href="/books/n/gene/cadasil/">CADASIL</a> [<a class="bk_pop" href="#alzheimer.REF.loy.2014.828">Loy et al 2014</a>, <a class="bk_pop" href="#alzheimer.REF.ferrari.2018.615">Ferrari et al 2018</a>].</div></li></ul></div><div id="alzheimer._escape__2_Causes_of_Alzheimer"><h2 id="_alzheimer__escape__2_Causes_of_Alzheimer_">2. Causes of Alzheimer Disease</h2><div id="alzheimer.T.causes_of_alzheimer_disease" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Causes of Alzheimer Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1161/table/alzheimer.T.causes_of_alzheimer_disease/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alzheimer.T.causes_of_alzheimer_disease_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cause</th><th id="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of Cases</th></tr></thead><tbody><tr><td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Late-onset <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a>&#x000a0;<sup>1</sup> (age &#x0003e;60-65 years)</td><td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%-25%</td></tr><tr><td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Early-onset <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a>&#x000a0;<sup>1</sup> (age &#x0003c;60-65 years)</td><td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">&#x0003c;2%</td></tr><tr><td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Down syndrome&#x000a0;<sup>2</sup></td><td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td></tr><tr><td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown (includes genetic/environment interactions)</td><td headers="hd_h_alzheimer.T.causes_of_alzheimer_disease_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~75%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="alzheimer.TF.1.1"><p class="no_margin">&#x02265;3 persons in a family with AD</p></div></dd><dt>2. </dt><dd><div id="alzheimer.TF.1.2"><p class="no_margin">Essentially all persons with Down syndrome (trisomy 21) develop the neuropathologic hallmarks of AD after age 40 years [<a class="bk_pop" href="#alzheimer.REF.mccarron.2017.843">McCarron et al 2017</a>]. If carefully observed or tested, more than half of individuals with DS also show clinical evidence of cognitive decline. The presumed reason for this association is the lifelong overexpression of <i>APP</i> on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 21 encoding the amyloid precursor protein and the resultant overproduction of &#x003b2;-amyloid in the brains of persons who are trisomic for this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd></dl></div></div></div><div id="alzheimer.Familial_Alzheimer_Disease"><h3>Familial Alzheimer Disease</h3><p>Approximately 25% of all AD is <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> (i.e., &#x02265;3 persons in a family have AD) and 75% is nonfamilial (i.e., an individual with AD and no known family history of AD). Because familial AD and nonfamilial AD appear to have the same clinical and pathologic phenotypes, they can only be distinguished by family history and/or by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><div id="alzheimer.LateOnset_Familial_AD"><h4>Late-Onset Familial AD</h4><p>Investigations have supported the concept that late-onset AD (age &#x0003e;60-65 years) is a complex disorder that may involve multiple susceptibility genes [<a class="bk_pop" href="#alzheimer.REF.van_cauwenberghe.2016.421">Van Cauwenberghe et al 2016</a>].</p><p>While the association of the <i>APOE</i> e4 <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> with AD is significant, <i>APOE</i> <a class="def" href="/books/n/gene/glossary/def-item/genotyping/">genotyping</a> is neither fully specific nor sensitive. While <i>APOE</i> genotyping may have an adjunct role in the diagnosis of AD in symptomatic individuals, it appears to have little role at this time in predictive testing of asymptomatic individuals. As reviewed and summarized by <a class="bk_pop" href="#alzheimer.REF.van_cauwenberghe.2016.421">Van Cauwenberghe et al [2016]</a>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>APOE</i> has three major allelic variants &#x02013; e2, e3, and e4 &#x02013; which encode different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> of the protein ApoE. The presence of the <i>APOE</i> e4 allele in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state (<i>APOE</i> e3/e4) or the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> state (<i>APOE</i> e4/e4) increases the risk for early-onset and late-onset AD but is not sufficient to cause disease. Only 20%-25% of individuals in the general population are heterozygous or homozygous for the e4 allele compared to 20%-65% of individuals with AD. The risk effect is estimated to be threefold for heterozygotes (<i>APOE</i> e3/e4) and 15-fold for homozygotes (<i>APOE</i> e4/e4). Using data from community-based samples, <a class="bk_pop" href="#alzheimer.REF.qian.2017.e1002254">Qian et al [2017]</a> determined that a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> for an <i>APO</i> e4 allele has about a 10%-20% chance of developing AD by age 75, whereas an <i>APO</i> e4 homozygote has about a 25%-35% risk.</p><p>Approximately 42% of persons with AD do <b>not</b> have an <i>APOE</i> e4 <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. The absence of an <i>APOE</i> e4 allele does not rule out the diagnosis of AD.</p><p>Of note, the <i>APOE</i> e2 <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> appears to have a protective effect [<a class="bk_pop" href="#alzheimer.REF.iacono.2015.14082">Iacono et al 2015</a>].</p></div><div id="alzheimer.Susceptibility_Genes"><h4>Susceptibility Genes</h4><p>Research studies have identified variants in ~20 genes that increase the risk of AD slightly (i.e., &#x0003c;2%). Many of these genes have a role in brain development, cytoskeletal organization, and immune function. Variants in these susceptibility genes differ from variants in genes known to cause Alzheimer disease as no variant in any of these genes "causes" AD; therefore, these genes should not be included in any diagnostic testing (see <a href="#alzheimer._escape__3_Evaluation_Strategi">Evaluation Strategies</a>).</p><p>Furthermore, it should be noted that while various combinations of variants in these genes have been proposed as markers for genetic risk of developing AD (so-called "<a class="def" href="/books/n/gene/glossary/def-item/polygenic/">polygenic</a> risk scores") [<a class="bk_pop" href="#alzheimer.REF.desikan.2017.e1002258">Desikan et al 2017</a>, <a class="bk_pop" href="#alzheimer.REF.tan.2017.484">Tan et al 2017</a>, <a class="bk_pop" href="#alzheimer.REF.tosto.2017.1180">Tosto et al 2017</a>], at present these risk scores are of no known clinical utility.</p><p>The following list of susceptibility genes is based on reviews by <a class="bk_pop" href="#alzheimer.REF.naj.2014.1394">Naj et al [2014]</a>, <a class="bk_pop" href="#alzheimer.REF.delaguila.2015.49">Del-Aguila et al [2015]</a>, <a class="bk_pop" href="#alzheimer.REF.ridge.2016.200.e13">Ridge et al [2016]</a>, <a class="bk_pop" href="#alzheimer.REF.van_cauwenberghe.2016.421">Van Cauwenberghe et al [2016]</a>, and <a class="bk_pop" href="#alzheimer.REF.yokoyama.2016.691">Yokoyama et al [2016]</a>: <i>ABCA7</i>, <i>AKAP9</i>, <i>BIN1</i>, <i>CASS4</i>, <i>CD2AP</i>, <i>CD33</i>, <i>CLU</i>, <i>EPHA1</i>, <i>FERMT2</i>, <i>HLA-DRB5/DRB1</i>, <i>INPP5D</i>, <i>MEF2C</i>, <i>MS4A6A/MS4A4E</i>, <i>PICALM</i>, <i>PLD3</i>, <i>PTK2B</i>, <i>SORL1</i>, <i>TREM2</i> (see NOTE), and <i>UNC5C.</i></p><p>NOTE: The <i>TREM2</i> p.Arg47His variant is a statistically significant risk factor for late-onset AD [<a class="bk_pop" href="#alzheimer.REF.guerreiro.2013.117">Guerreiro et al 2013</a>, <a class="bk_pop" href="#alzheimer.REF.jonsson.2013.107">Jonsson et al 2013</a>]. Although this variant in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state is rare in the general population (0.5%-1%), it results in an odds ratio of about 3.0 for the occurrence of AD. In a large family, apparent interaction of this variant with the <i>APOE</i> e4 <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> increased the risk for late-onset AD [<a class="bk_pop" href="#alzheimer.REF.korvatska.2015.920">Korvatska et al 2015</a>].</p><p>See <a href="/books/NBK1161/bin/alzheimer-Table2.pdf">Table 2</a> (pdf) for potential functional contribution to Alzheimer disease risk.</p></div><div id="alzheimer.EarlyOnset_Familial_AD"><h4>Early-Onset Familial AD</h4><p>Early-onset <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> AD (EOFAD) refers to AD that occurs in multiple members of a family with a mean onset usually before age 65 years. The dementia <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is similar to that of late-onset AD, sometimes with a long prodrome [<a class="bk_pop" href="#alzheimer.REF.schellenberg.2012.305">Schellenberg &#x00026; Montine 2012</a>]. The genes causative of EOFAD and associated ages of onset are summarized in <a class="figpopup" href="/books/NBK1161/table/alzheimer.T.earlyonset_familial_alzheime/?report=objectonly" target="object" rid-figpopup="figalzheimerTearlyonsetfamilialalzheime" rid-ob="figobalzheimerTearlyonsetfamilialalzheime">Table 3</a>.</p><div id="alzheimer.T.earlyonset_familial_alzheime" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Early-Onset Familial Alzheimer Disease (EOFAD)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1161/table/alzheimer.T.earlyonset_familial_alzheime/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alzheimer.T.earlyonset_familial_alzheime_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of EOFAD&#x000a0;<sup>2</sup></th><th id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Age of Onset (yrs)</th><th id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Other</th></tr><tr><th headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_1" id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>APP</i></th><th headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_2" id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%-15%</th><th headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_3" id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually 40s &#x00026; 50s, occasionally 60s (range 30-65)&#x000a0;<sup>3</sup></th><th headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_4" id="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"></th></tr></thead><tbody><tr><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_1 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PSEN1</i></td><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_2 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20%-70%</td><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_3 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually 40s or early 50s (range 30s-early 60s); onset after age 65 thought to be rare</td><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_4 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_4" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Relatively rapid progression over 6-7 yrs is common.</div></li><li class="half_rhythm"><div>Often associated w/seizures, myoclonus, &#x00026; language deficits&#x000a0;<sup>4</sup></div></li><li class="half_rhythm"><div>Founder variants identified in residents of the state of Antioquia, Colombia&#x000a0;<sup>5</sup> &#x00026; in Caribbean Hispanics&#x000a0;<sup>6</sup></div></li></ul></td></tr><tr><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_1 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PSEN2</i></td><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_2 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%</td><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_3 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">40-75</td><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_4 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_4" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Mean duration: 11 yrs</div></li><li class="half_rhythm"><div>Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> (i.e., asymptomatic heterozygotes age &#x0003e;80 yrs) reported&#x000a0;<sup>7</sup></div></li><li class="half_rhythm"><div>Founder variant identified in the Volga German population</div></li></ul></td></tr><tr><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_1 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_2 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20%-40%&#x000a0;<sup>8</sup></td><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_3 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_3 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_4 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_4" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_1_4 hd_h_alzheimer.T.earlyonset_familial_alzheime_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No major new <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for EOFAD has been identified because of overlap in the clinical presentation of AD and FTD caused by pathogenic variants in <i>MAPT</i>, <i>GRN</i>, <i>C9orf72.</i></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = Alzheimer disease; FTD = frontotemporal dementia</p></div></dd><dt>1. </dt><dd><div id="alzheimer.TF.3.1"><p class="no_margin">Genes are in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="alzheimer.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#alzheimer.REF.schellenberg.2012.305">Schellenberg &#x00026; Montine [2012]</a></p></div></dd><dt>3. </dt><dd><div id="alzheimer.TF.3.3"><p class="no_margin"><a class="bk_pop" href="#alzheimer.REF.pilotto.2013.689591">Pilotto et al [2013]</a></p></div></dd><dt>4. </dt><dd><div id="alzheimer.TF.3.4"><p class="no_margin"><a class="bk_pop" href="#alzheimer.REF.larner.2013.653">Larner [2013]</a>, <a class="bk_pop" href="#alzheimer.REF.ryman.2014.253">Ryman et al [2014]</a></p></div></dd><dt>5. </dt><dd><div id="alzheimer.TF.3.5"><p class="no_margin"><a class="bk_pop" href="#alzheimer.REF.lalli.2014">Lalli et al [2014]</a></p></div></dd><dt>6. </dt><dd><div id="alzheimer.TF.3.6"><p class="no_margin"><a class="bk_pop" href="#alzheimer.REF.lee.2014.430">Lee et al [2014]</a></p></div></dd><dt>7. </dt><dd><div id="alzheimer.TF.3.7"><p class="no_margin"><a class="bk_pop" href="#alzheimer.REF.jayadev.2010.1143">Jayadev et al [2010]</a></p></div></dd><dt>8. </dt><dd><div id="alzheimer.TF.3.8"><p class="no_margin">It is likely that pathogenic variants in other genes causative of EOFAD will be identified because kindreds with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> FAD with no known pathogenic variants in <i>PSEN1</i>, <i>PSEN2</i>, or <i>APP</i> have been described [<a class="bk_pop" href="#alzheimer.REF.pasanen.2018.827">Pasanen et al 2018</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="alzheimer._escape__3_Evaluation_Strategi"><h2 id="_alzheimer__escape__3_Evaluation_Strategi_">3. Evaluation Strategies to Identify the Genetic Cause of Alzheimer Disease in a Proband</h2><p>Establishing a specific genetic cause of Alzheimer disease (AD):</p><ul><li class="half_rhythm"><div>Can aid in discussions of prognosis (which are beyond the scope of this <i>GeneReview</i>) and <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (Section 4);</div></li><li class="half_rhythm"><div>Usually involves a medical history, physical examination, and laboratory testing to exclude disorders included in the differential diagnosis (see Section 1), family history, and <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a>/genetic testing.</div></li></ul><p>The two most important indicators of a genetic form of AD are age of onset (<a class="figpopup" href="/books/NBK1161/table/alzheimer.T.earlyonset_familial_alzheime/?report=objectonly" target="object" rid-figpopup="figalzheimerTearlyonsetfamilialalzheime" rid-ob="figobalzheimerTearlyonsetfamilialalzheime">Table 3</a>) and positive family history of dementia.</p><ul><li class="half_rhythm"><div>There is no specific age cutoff and the general rule is that in a single individual diagnosed with AD, the earlier the onset, the more likely a genetic cause. Onset before 50 years has the highest likelihood of a genetic cause and after 70 years the lowest.</div></li><li class="half_rhythm"><div>A positive family history (&#x02265;3 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons) of early-onset dementia increases the probability of a genetic cause.</div></li></ul><p><b>Family history.</b> A three-generation family history should be taken, with attention to relatives with manifestations of AD and documentation of relevant findings through direct examination or review of medical records, including results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p><b>Molecular genetic testing approaches</b> can include a combination of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> or <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>). Gene-targeted testing requires the clinician to hypothesize which gene(s) are likely involved, whereas genomic testing does not.</p><p>Because of the significant overlap in clinical manifestations and age of onset in AD, single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (i.e., <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> (see NOTE) that includes <i>APOE</i> (specifically for detection and interpretation of the e4 <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>) and all three genes listed in <a class="figpopup" href="/books/NBK1161/table/alzheimer.T.earlyonset_familial_alzheime/?report=objectonly" target="object" rid-figpopup="figalzheimerTearlyonsetfamilialalzheime" rid-ob="figobalzheimerTearlyonsetfamilialalzheime">Table 3</a> is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. (5) Because Alzheimer disease susceptibility genes (<a href="/books/NBK1161/bin/alzheimer-Table2.pdf">Table 2</a>) are not "causative," they should not be included in a multigene panel.</p><p>NOTE: Some laboratories offer multigene panels for "neurodegenerative disorders." While the genes included in such panels are likely to vary significantly by laboratory, often the genes known to cause the disorders mentioned in the differential diagnosis of AD (see <a href="#alzheimer._escape__1_Clinical_Characteri">Section 1</a>), such as Parkinson disease, FTD, ALS, and prion-related disorders, are included. Because the clinical diagnosis of AD is usually "possible" or "probable" rather than "definite," it frequently is reasonable to use such a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) may be considered if a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> does not identify a cause for the findings that prompted testing. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible. If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p></div><div id="alzheimer._escape__4_Inform_Genetic_Coun"><h2 id="_alzheimer__escape__4_Inform_Genetic_Coun_">4. Inform Genetic Counseling of Family Members of an Individual with Alzheimer Disease</h2><div id="alzheimer.Risk_to_Family_Members__Nonfam"><h3>Risk to Family Members &#x02013; Nonfamilial Alzheimer Disease</h3><p>Genetic counseling for people with late-onset nonfamilial AD (i.e., an individual with AD and no known family history) and their family members must be empiric and relatively nonspecific. First-degree relatives of a person with nonfamilial AD have a cumulative lifetime risk of developing AD of approximately 15%-39%, which is typically reported as a 20%-25% risk [<a class="bk_pop" href="#alzheimer.REF.farrer.1989.485">Farrer et al 1989</a>, <a class="bk_pop" href="#alzheimer.REF.silverman.1994.577">Silverman et al 1994</a>, <a class="bk_pop" href="#alzheimer.REF.lautenschlager.1996.641">Lautenschlager et al 1996</a>]. This risk is approximately two to three times that of the <a class="def" href="/books/n/gene/glossary/def-item/background-risk/">background risk</a> (~27% vs 10.4%) [<a class="bk_pop" href="#alzheimer.REF.cupples.2004.192">Cupples et al 2004</a>].</p><p>Disagreement exists as to whether the age of onset of AD in a person with nonfamilial AD changes the risk to first-degree relatives. <a class="bk_pop" href="#alzheimer.REF.silverman.2005.565">Silverman et al [2005]</a> found that the risk to relatives of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with nonfamilial AD decreases with increasing age of onset of the proband.</p></div><div id="alzheimer.Risk_to_Family_Members__LateOn"><h3>Risk to Family Members &#x02013; Late-Onset Familial Alzheimer Disease (LOFAD)</h3><p>Inheritance of LOFAD (i.e., &#x02265;3 persons in a family have AD) is thought to be <a class="def" href="/books/n/gene/glossary/def-item/multifactorial/">multifactorial</a> and potentially involve multiple susceptibility genes [<a class="bk_pop" href="#alzheimer.REF.van_cauwenberghe.2016.421">Van Cauwenberghe et al 2016</a>]. First-degree relatives of a person with LOFAD have a cumulative lifetime risk of developing AD of ~15%-25%, which is ~1.5-2 times the risk of the general population. When both parents have AD (i.e., conjugal AD) risk to their children is at least twice that of the general population risk [<a class="bk_pop" href="#alzheimer.REF.jayadev.2008.373">Jayadev et al 2008</a>].</p></div><div id="alzheimer.Risk_to_Family_Members__APP_PS"><h3>Risk to Family Members &#x02013; <i>APP-</i>, <i>PSEN1-</i>, or <i>PSEN2-</i>Related Early-Onset Familial Alzheimer Disease (EOFAD)</h3><p>EOFAD in which an individual has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>APP</i>, <i>PSEN1</i>, or <i>PSEN2</i> represents an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disease. This section refers only to families having a known EOFAD-causing <i>APP</i>, <i>PSEN1</i>, or <i>PSEN2</i> pathogenic variant. Guidelines for counseling these families have been published [<a class="bk_pop" href="#alzheimer.REF.goldman.2011.597">Goldman et al 2011</a>].</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed as having <i>APP-</i>, <i>PSEN1-</i>, or <i>PSEN2</i>-related EOFAD have had an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div><ul><li class="half_rhythm"><div>Because the onset of EOFAD is typically in early adulthood and the progression is rapid, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parents are not alive at the time of diagnosis of their children.</div></li><li class="half_rhythm"><div>Occasionally, neither parent is identified as having had AD, but a <a class="def" href="/books/n/gene/glossary/def-item/second-degree-relative/">second-degree relative</a> (e.g., an uncle, aunt, and/or grandparent) has or had EOFAD. In this instance, a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is presumed to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> AD-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> associated with reduced (age-related) <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</div></li></ul></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with EOFAD may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, although this has not been documented.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with EOFAD may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or reduced (age-related) <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Therefore, an apparently negative family history cannot be considered confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the clinical/genetic status of the parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> was <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>APP-</i>, <i>PSEN1-</i>, or <i>PSEN2</i>-related EOFAD <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to sibs of having inherited the variant is 50%.</div></li><li class="half_rhythm"><div>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still presumed to be at increased risk for EOFAD because of the possibility of reduced (age-related) <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>APP-</i>, <i>PSEN1-</i>, or <i>PSEN2</i>-related EOFAD has a 50% chance of inheriting the EOFAD-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="alzheimer.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p><b>Predictive testing for <i>APP-</i>, <i>PSEN1-</i>, or <i>PSEN2</i>-related EOFAD (i.e., testing of asymptomatic at-risk individuals)</b></p><ul><li class="half_rhythm"><div>Predictive testing for asymptomatic adults at risk for <i>APP-</i>, <i>PSEN1-</i>, or <i>PSEN2</i>-related EOFAD is possible if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member. It should be remembered that testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.</div></li><li class="half_rhythm"><div>Potential consequences of such testing (including, but not limited to, socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals with a positive test result) as well as the capabilities and limitations of predictive testing should be discussed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to testing.</div></li></ul><p><b>Predictive testing for <i>APP-</i>, <i>PSEN1-</i>, or <i>PSEN2</i>-related</b>
<b>EOFAD in minors (i.e., testing of asymptomatic at-risk individuals younger than age 18 years)</b></p><ul><li class="half_rhythm"><div>For asymptomatic minors at risk for adult-onset conditions for which early treatment would have no beneficial effect on disease morbidity and mortality, predictive genetic testing is considered inappropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</div></li><li class="half_rhythm"><div>For more information, see the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</div></li></ul><p>In a family with an established diagnosis of EOFAD, it is appropriate to consider testing of symptomatic individuals regardless of age.</p><p><b><i>APOE</i> <a class="def" href="/books/n/gene/glossary/def-item/genotyping/">genotyping</a>.</b> At this time, it is generally agreed that <i>APOE</i> genotyping has little role in predictive testing. The presence of one or two copies of the <i>APOE</i> e4 <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> increases the lifetime risk of AD in an asymptomatic individual but does not constitute a diagnosis of AD (i.e., an individual may have one or two copies of the <i>APOE</i> e4 allele and never develop AD). Likewise, absence of one or two copies of the <i>APOE</i> e4 allele does not eliminate the risk for AD in an asymptomatic individual (~42% of persons with AD do not have an <i>APOE</i> e4 allele).</p><ul><li class="half_rhythm"><div><b><i>APOE</i> e4/e4</b></div><ul><li class="half_rhythm"><div>A young asymptomatic female who is <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <i>APOE</i> e4 <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> has a 40%-45% probability of developing AD by age 75 years, compared with 10%-15% probability in the general female population.</div></li><li class="half_rhythm"><div>A young asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> male has a 25%-30% risk of developing AD by age 80 years, compared with 10%-15% probability in the general male population [<a class="bk_pop" href="#alzheimer.REF.breitner.1999.321">Breitner et al 1999</a>, <a class="bk_pop" href="#alzheimer.REF.qian.2017.e1002254">Qian et al 2017</a>, <a class="bk_pop" href="#alzheimer.REF.liu.2018.602">Liu &#x00026; Caselli 2018</a>].</div></li></ul></li><li class="half_rhythm"><div><b><i>APOE</i> e3/e4.</b> For an asymptomatic person <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>APOE</i> e4 <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, the lifetime risk of developing AD is lower (15%-25%) and the likely age of onset is later (peak age 80s) [<a class="bk_pop" href="#alzheimer.REF.breitner.1999.321">Breitner et al 1999</a>, <a class="bk_pop" href="#alzheimer.REF.neu.2017.1178">Neu et al 2017</a>, <a class="bk_pop" href="#alzheimer.REF.qian.2017.e1002254">Qian et al 2017</a>].</div></li></ul><p>See the <a href="https://alzfdn.org/genetesting/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Statement of The Alzheimer's Foundation of America (AFA) and AFA's Medical, Scientific and Memory Screening Advisory Board on Genetic Testing to Determine Risk of Alzheimer's Disease</a> and <a class="bk_pop" href="#alzheimer.REF.frank.2018.421">Frank et al [2018]</a> for further discussion of predictive testing for AD.</p></div></div><div id="alzheimer.Resources"><h2 id="_alzheimer_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Alzheimer's Association</b></div><div>225 North Michigan Avenue</div><div>Fl 17</div><div>Chicago IL 60601-7633</div><div><b>Phone:</b> 800-272-3900 (Toll-free 24/7 Helpline); 866-403-3073 (Toll-free 24/7 Helpline - TDD); 312-335-8700</div><div><b>Fax:</b> 866-335-5886 (toll-free)</div><div><b>Email:</b> info@alz.org</div><div><a href="http://www.alz.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.alz.org</a></div></li><li class="half_rhythm"><div><b>Alzheimer's Disease Education and Referral Center (ADEAR)</b></div><div>PO Box 8250</div><div>Silver Spring MD 20907</div><div><b>Phone:</b> 800-438-4380 (toll-free)</div><div><b>Fax:</b> 301-495-3334</div><div><b>Email:</b> adear@alzheimers.org</div><div><a href="http://www.nia.nih.gov/alzheimers" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nia.nih.gov/alzheimers</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/alzheimer-disease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alzheimer Disease</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22170/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alzheimer Disease</a></div></li><li class="half_rhythm"><div><b>National Institute on Aging</b></div><div>31 Center Drive</div><div>Building 31, Room 5C27</div><div>MSC 2292</div><div>Bethesda MD 20892</div><div><b>Phone:</b> 301-496-1752; 800-222-2225 (toll-free); 800-222-4225 (toll-free TTY)</div><div><b>Fax:</b> 301-496-1072</div><div><a href="http://www.nia.nih.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nia.nih.gov</a></div></li></ul></div><div id="alzheimer.References"><h2 id="_alzheimer_References_">References</h2><div id="alzheimer.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.bird.2008">Bird TD, Miller BL. Alzheimer's disease and primary dementias. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds. <em>Harrison's Principles of Internal Medicine.</em> 17 ed. New York, NY: McGraw-Hill; 2008:2393-406.</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.breitner.1999.321">Breitner JC, Wyse BW, Anthony JC, Welsh-Bohmer KA, Steffens DC, Norton MC, Tschanz JT, Plassman BL, Meyer MR, Skoog I, Khachaturian A. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">53</span>:321–31.</span> [<a href="/pubmed/10430421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10430421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.cupples.2004.192">Cupples LA, Farrer LA, Sadovnick AD, Relkin N, Whitehouse P, Green RC. Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. <span><span class="ref-journal">Genet Med. </span>2004;<span class="ref-vol">6</span>:192–6.</span> [<a href="/pubmed/15266206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15266206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.delaguila.2015.49">Del-Aguila JL, Koboldt DC, Black K, Chasse R, Norton J, Wilson RK, Cruchaga C. Alzheimer's disease: rare variants with large effect sizes. <span><span class="ref-journal">Curr Opin Genet Dev. </span>2015;<span class="ref-vol">33</span>:49–55.</span> [<a href="/pubmed/26311074" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26311074</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.desikan.2017.e1002258">Desikan RS, Fan CC, Wang Y, Schork AJ, Cabral HJ, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer JB, Karow DS, Kauppi K, Witoelar A, Karch CM, Bonham LW, Yokoyama JS, Rosen HJ, Miller BL, Dillon WP, Wilson DM, Hess CP, Pericak-Vance M, Haines JL, Farrer LA, Mayeux R, Hardy J, Goate AM, Hyman BT, Schellenberg GD, McEvoy LK, Andreassen OA, Dale AM. Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score. <span><span class="ref-journal">PLoS Med. </span>2017;<span class="ref-vol">14</span>:e1002258.</span> [<a href="/pmc/articles/PMC5360219/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5360219</span></a>] [<a href="/pubmed/28323831" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28323831</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.dubois.2014.614">Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. <span><span class="ref-journal">Lancet Neurol. </span>2014;<span class="ref-vol">13</span>:614–29.</span> [<a href="/pubmed/24849862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24849862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.farrer.1989.485">Farrer LA, O'Sullivan DM, Cupples LA, Growdon JH, Myers RH. Assessment of genetic risk for Alzheimer's disease among first-degree relatives. <span><span class="ref-journal">Ann Neurol. </span>1989;<span class="ref-vol">25</span>:485–93.</span> [<a href="/pubmed/2774490" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2774490</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.ferrari.2018.615">Ferrari C, Nacmias B, Sorbi S. The diagnosis of dementias: a practical tool not to miss rare causes. <span><span class="ref-journal">Neurol Sci. </span>2018;<span class="ref-vol">39</span>:615–27.</span> [<a href="/pubmed/29198043" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29198043</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.frank.2018.421">Frank L, Wesson Ashford J, Bayley PJ, Borson S, Buschke H, Cohen D, Cummings JL, Davies P, Dean M, Finkel SI, Hyer L, Perry G, Powers RE, Schmitt F. Genetic risk of Alzheimer&#x02019;s disease: three wishes now that the genie is out of the bottle. <span><span class="ref-journal">J Alzheimers Dis. </span>2018;<span class="ref-vol">66</span>:421–3.</span> [<a href="/pmc/articles/PMC6218128/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6218128</span></a>] [<a href="/pubmed/30282369" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30282369</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.gabelle.2015.672">Gabelle A, Schraen S, Gutierrez LA, Pays C, Rouaud O, Bu&#x000e9;e L, Touchon J, Helmer C, Lambert JC, Berr C. Plasma &#x003b2;-amyloid 40 levels are positively associated with mortality risks in the elderly. <span><span class="ref-journal">Alzheimers Dement. </span>2015;<span class="ref-vol">11</span>:672–80.</span> [<a href="/pubmed/25022539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25022539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.goldman.2011.597">Goldman JS, Hahn SE, Catania JW, LaRusse-Eckert S, Butson MB, Rumbaugh M, Strecker MN, Roberts JS, Burke W, Mayeux R, Bird T, et al.  Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. <span><span class="ref-journal">Genet Med. </span>2011;<span class="ref-vol">13</span>:597–605.</span> [<a href="/pmc/articles/PMC3326653/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3326653</span></a>] [<a href="/pubmed/21577118" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21577118</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.guerreiro.2013.117">Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J, et al.  TREM2 variants in Alzheimer's disease. <span><span class="ref-journal">N Engl J Med. </span>2013;<span class="ref-vol">368</span>:117–27.</span> [<a href="/pmc/articles/PMC3631573/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3631573</span></a>] [<a href="/pubmed/23150934" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23150934</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.iacono.2015.14082">Iacono D, Zandi P, Gross M, Markesbery WR, Pletnikova O, Rudow G, Troncoso JC. APO&#x003b5;2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study. <span><span class="ref-journal">Oncotarget. </span>2015;<span class="ref-vol">6</span>:14082–91.</span> [<a href="/pmc/articles/PMC4546453/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4546453</span></a>] [<a href="/pubmed/26101858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26101858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.james.2016.2983">James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. <span><span class="ref-journal">Brain. </span>2016;<span class="ref-vol">139</span>:2983–93.</span> [<a href="/pmc/articles/PMC5091047/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5091047</span></a>] [<a href="/pubmed/27694152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27694152</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.jayadev.2010.1143">Jayadev S, Leverenz JB, Steinbart E, Stahl J, Klunk W, Yu CE, Bird TD. Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. <span><span class="ref-journal">Brain. </span>2010;<span class="ref-vol">133</span>:1143–54.</span> [<a href="/pmc/articles/PMC2850581/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2850581</span></a>] [<a href="/pubmed/20375137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20375137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.jayadev.2008.373">Jayadev S, Steinbart EJ, Chi YY, Kukull WA, Schellenberg GD, Bird TD. Conjugal Alzheimer disease: risk in children when both parents have Alzheimer disease. <span><span class="ref-journal">Arch Neurol. </span>2008;<span class="ref-vol">65</span>:373–8.</span> [<a href="/pubmed/18332250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18332250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.jonsson.2013.107">Jonsson T, Stefansson H, Ph D SS, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K. Variant of TREM2 associated with the risk of Alzheimer's disease. <span><span class="ref-journal">N Engl J Med. </span>2013;<span class="ref-vol">368</span>:107–16.</span> [<a href="/pmc/articles/PMC3677583/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3677583</span></a>] [<a href="/pubmed/23150908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23150908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.korvatska.2015.920">Korvatska O, Leverenz JB, Jayadev S, McMillan P, Kurtz I, Guo X, Rumbaugh M, Matsushita M, Girirajan S, Dorschner MO, Kiianitsa K, Yu CE, Brkanac Z, Garden GA, Raskind WH, Bird TD. R47H variant of TREM2 associated with Alzheimer disease in a large late-onset family: clinical, genetic, and neuropathological study. <span><span class="ref-journal">JAMA Neurol. </span>2015;<span class="ref-vol">72</span>:920–7.</span> [<a href="/pmc/articles/PMC4825672/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4825672</span></a>] [<a href="/pubmed/26076170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26076170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.lalli.2014">Lalli MA, Cox HC, Arcila ML, Cadavid L, Moreno S, Garcia G, Madrigal L, Reiman EM, Arcos-Burgos M, Bedoya G, Brunkow ME, Glusman G, Roach JC, Hood L, Kosik KS, Lopera F. Origin of the PSEN1 E280A mutation causing early-onset Alzheimer's disease. Alzheimers Dement. 2014;10:S277-S283.e10. [<a href="/pmc/articles/PMC4019728/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4019728</span></a>] [<a href="/pubmed/24239249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24239249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.larner.2013.653">Larner AJ. Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships. <span><span class="ref-journal">J Alzheimers Dis. </span>2013;<span class="ref-vol">37</span>:653–9.</span> [<a href="/pubmed/23948899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23948899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.lautenschlager.1996.641">Lautenschlager NT, Cupples LA, Rao VS, Auerbach SA, Becker R, Burke J, Chui H, Duara R, Foley EJ, Glatt SL, Green RC, Jones R, Karlinsky H, Kukull WA, Kurz A, Larson EB, Martelli K, Sadovnick AD, Volicer L, Waring SC, Growdon JH, Farrer LA. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: what is in store for the oldest old? <span><span class="ref-journal">Neurology. </span>1996;<span class="ref-vol">46</span>:641–50.</span> [<a href="/pubmed/8618660" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8618660</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.lee.2014.430">Lee JH, Kahn A, Cheng R, Reitz C, Vardarajan B, Lantigua R, Medrano M, Jim&#x000e9;nez-Vel&#x000e1;zquez IZ, Williamson J, Nagy P, Mayeux R. Disease-related mutations among Caribbean Hispanics with familial dementia. <span><span class="ref-journal">Mol Genet Genomic Med. </span>2014;<span class="ref-vol">2</span>:430–7.</span> [<a href="/pmc/articles/PMC4190878/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4190878</span></a>] [<a href="/pubmed/25333068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25333068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.lemstra.2017.113">Lemstra AW, de Beer MH, Teunissen CE, Schreuder C, Scheltens P, van der Flier WM, Sikkes SA. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2017;<span class="ref-vol">88</span>:113–8.</span> [<a href="/pubmed/27794030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27794030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.liu.2018.602">Liu L, Caselli RJ. Age stratification corrects bias in estimated hazard of APOE genotype for Alzheimer's disease. <span><span class="ref-journal">Alzheimers Dement (N Y). </span>2018;<span class="ref-vol">4</span>:602–8.</span> [<a href="/pmc/articles/PMC6226550/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6226550</span></a>] [<a href="/pubmed/30450407" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30450407</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.loy.2014.828">Loy CT, Schofield PR, Turner AM, Kwok JB. Genetics of dementia. <span><span class="ref-journal">Lancet. </span>2014;<span class="ref-vol">383</span>:828–40.</span> [<a href="/pubmed/23927914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23927914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.mattsson.2018.e388">Mattsson N, Smith R, Strandberg O, Palmqvist S, Sch&#x000f6;ll M, Insel PS, H&#x000e4;gerstr&#x000f6;m D, Ohlsson T, Zetterberg H, Blennow K, J&#x000f6;gi J, Hansson O. Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease. <span><span class="ref-journal">Neurology. </span>2018;<span class="ref-vol">90</span>:e388–e395.</span> [<a href="/pmc/articles/PMC5791788/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5791788</span></a>] [<a href="/pubmed/29321235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29321235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.mccarron.2017.843">McCarron M, McCallion P, Reilly E, Dunne P, Carroll R, Mulryan N. A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome. <span><span class="ref-journal">J Intellect Disabil Res. </span>2017;2017;<span class="ref-vol">61</span>:843–52.</span> [<a href="/pubmed/28664561" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28664561</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.montine.2012.1">Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT, et al.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. <span><span class="ref-journal">Acta Neuropathol. </span>2012;<span class="ref-vol">123</span>:1–11.</span> [<a href="/pmc/articles/PMC3268003/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3268003</span></a>] [<a href="/pubmed/22101365" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22101365</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.naj.2014.1394">Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, Baldwin CT, Jarvik GP, Crane PK, Rogaeva E, Barmada MM, Demirci FY, Cruchaga C, Kramer PL, Ertekin-Taner N, Hardy J, Graff-Radford NR, Green RC, Larson EB, St George-Hyslop PH, Buxbaum JD, Evans DA, Schneider JA, Lunetta KL, Kamboh MI, Saykin AJ, Reiman EM, De Jager PL, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Martin ER, Haines JL, Mayeux RP, et al.  Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. <span><span class="ref-journal">JAMA Neurol. </span>2014;<span class="ref-vol">71</span>:1394–404.</span> [<a href="/pmc/articles/PMC4314944/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4314944</span></a>] [<a href="/pubmed/25199842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25199842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.neu.2017.1178">Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, Wang LS, Romero K, Arneric SP, Redolfi A, Orlandi D, Frisoni GB, Au R, Devine S, Auerbach S, Espinosa A, Boada M, Ruiz A, Johnson SC, Koscik R, Wang JJ, Hsu WC, Chen YL, Toga AW. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis. <span><span class="ref-journal">JAMA Neurol. </span>2017;<span class="ref-vol">74</span>:1178–89.</span> [<a href="/pmc/articles/PMC5759346/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5759346</span></a>] [<a href="/pubmed/28846757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28846757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.pasanen.2018.827">Pasanen P, Myllykangas L, P&#x000f6;yh&#x000f6;nen M, Kiviharju A, Siitonen M, Hardy J, Bras J, Paetau A, Tienari PJ, Guerreiro R, Verkkoniemi-Ahola A. Genetics of dementia in a Finnish cohort. <span><span class="ref-journal">Eur J Hum Genet. </span>2018;<span class="ref-vol">26</span>:827–37.</span> [<a href="/pmc/articles/PMC5974394/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5974394</span></a>] [<a href="/pubmed/29476165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29476165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.pilotto.2013.689591">Pilotto A, Padovani A, Borroni B. Clinical, biological, and imaging features of monogenic Alzheimer's disease. <span><span class="ref-journal">Biomed Res Int. </span>2013;<span class="ref-vol">2013</span>:689591.</span> [<a href="/pmc/articles/PMC3860086/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3860086</span></a>] [<a href="/pubmed/24377094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24377094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.qian.2017.e1002254">Qian J, Wolters FJ, Beiser A, Haan M, Ikram MA, Karlawish J, Langbaum JB, Neuhaus JM, Reiman EM, Roberts JS, Seshadri S, Tariot PN, Woods BM, Betensky RA, Blacker D. APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts. <span><span class="ref-journal">PLoS Med. </span>2017;<span class="ref-vol">14</span>:e1002254.</span> [<a href="/pmc/articles/PMC5360223/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5360223</span></a>] [<a href="/pubmed/28323826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28323826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.ridge.2016.200.e13">Ridge PG, Hoyt KB, Boehme K, Mukherjee S, Crane PK, Haines JL, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD, Kauwe JSK, et al.  Assessment of the genetic variance of late-onset Alzheimer's disease. <span><span class="ref-journal">Neurobiol Aging. </span>2016;<span class="ref-vol">41</span>:200.e13–200.e20.</span> [<a href="/pmc/articles/PMC4948179/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4948179</span></a>] [<a href="/pubmed/27036079" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27036079</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.ryman.2014.253">Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, Moreno S, Reiman EM, Ringman JM, Salloway S, Schofield PR, Sperling R, Tariot PN, Xiong C, Morris JC, Bateman RJ, et al.  Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">83</span>:253–60.</span> [<a href="/pmc/articles/PMC4117367/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4117367</span></a>] [<a href="/pubmed/24928124" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24928124</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.schellenberg.2012.305">Schellenberg GD, Montine TJ. The genetics and neuropathology of Alzheimer's disease. <span><span class="ref-journal">Acta Neuropathol. </span>2012;<span class="ref-vol">124</span>:305–23.</span> [<a href="/pmc/articles/PMC3708460/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3708460</span></a>] [<a href="/pubmed/22618995" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22618995</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.silverman.2005.565">Silverman JM, Ciresi G, Smith CJ, Marin DB, Schnaider-Beeri M. Variability of familial risk of Alzheimer disease across the late life span. <span><span class="ref-journal">Arch Gen Psychiatry. </span>2005;<span class="ref-vol">62</span>:565–73.</span> [<a href="/pubmed/15867110" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15867110</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.silverman.1994.577">Silverman JM, Li G, Zaccario ML, Smith CJ, Schmeidler J, Mohs RC, Davis KL. Patterns of risk in first-degree relatives of patients with Alzheimer's disease. <span><span class="ref-journal">Arch Gen Psychiatry. </span>1994;<span class="ref-vol">51</span>:577–86.</span> [<a href="/pubmed/8031231" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8031231</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.sutphen.2015.1029">Sutphen CL, Jasielec MS, Shah AR, Macy EM, Xiong C, Vlassenko AG, Benzinger TL, Stoops EE, Vanderstichele HM, Brix B, Darby HD, Vandijck ML, Ladenson JH, Morris JC, Holtzman DM, Fagan AM. Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age. <span><span class="ref-journal">JAMA Neurol. </span>2015;<span class="ref-vol">72</span>:1029–42.</span> [<a href="/pmc/articles/PMC4570860/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4570860</span></a>] [<a href="/pubmed/26147946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26147946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.tan.2017.484">Tan CH, Hyman BT, Tan JJX, Hess CP, Dillon WP, Schellenberg GD, Besser LM, Kukull WA, Kauppi K, McEvoy LK, Andreassen OA, Dale AM, Fan CC, Desikan RS. Polygenic hazard scores in preclinical Alzheimer disease. <span><span class="ref-journal">Ann Neurol. </span>2017;<span class="ref-vol">82</span>:484–8.</span> [<a href="/pmc/articles/PMC5758043/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5758043</span></a>] [<a href="/pubmed/28940650" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28940650</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.tosto.2017.1180">Tosto G, Bird TD, Tsuang D, Bennett DA, Boeve BF, Cruchaga C, Faber K, Foroud TM, Farlow M, Goate AM, Bertlesen S, Graff-Radford NR, Medrano M, Lantigua R, Manly J, Ottman R, Rosenberg R, Schaid DJ, Schupf N, Stern Y, Sweet RA, Mayeux R. Polygenic risk scores in familial Alzheimer disease. <span><span class="ref-journal">Neurology. </span>2017;<span class="ref-vol">88</span>:1180–6.</span> [<a href="/pmc/articles/PMC5373783/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5373783</span></a>] [<a href="/pubmed/28213371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28213371</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.van_cauwenberghe.2016.421">Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. <span><span class="ref-journal">Genet Med. </span>2016;<span class="ref-vol">18</span>:421–30.</span> [<a href="/pmc/articles/PMC4857183/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4857183</span></a>] [<a href="/pubmed/26312828" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26312828</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alzheimer.REF.yokoyama.2016.691">Yokoyama JS, Wang Y, Schork AJ, Thompson WK, Karch CM, Cruchaga C, McEvoy LK, Witoelar A, Chen CH, Holland D, Brewer JB, Franke A, Dillon WP, Wilson DM, Mukherjee P, Hess CP, Miller Z, Bonham LW, Shen J, Rabinovici GD, Rosen HJ, Miller BL, Hyman BT, Schellenberg GD, Karlsen TH, Andreassen OA, Dale AM, Desikan RS, et al.  Association between genetic traits for immune-mediated diseases and Alzheimer disease. <span><span class="ref-journal">JAMA Neurol. </span>2016;<span class="ref-vol">73</span>:691–7.</span> [<a href="/pmc/articles/PMC4905783/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4905783</span></a>] [<a href="/pubmed/27088644" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27088644</span></a>]</div></li></ul></div></div><div id="alzheimer.Chapter_Notes"><h2 id="_alzheimer_Chapter_Notes_">Chapter Notes</h2><div id="alzheimer.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>20 December 2018 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 September 2015 (tb) Revision: revisions to late-onset <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> AD; citations added</div></li><li class="half_rhythm"><div>3 April 2014 (tb) Revision: <i>PLD3</i> included [Cruchaga et al 2014]</div></li><li class="half_rhythm"><div>30 January 2014 (tb) Revision: addition of information about new AD susceptibility loci</div></li><li class="half_rhythm"><div>3 July 2013 (tb) Revision: <i>CD33</i> included [Griciuc et al 2013]</div></li><li class="half_rhythm"><div>13 December 2012 (tb) Revision: p.Arg47His allelic variant in <i>TREM2</i> found to be a risk factor for late-onset AD [<a class="bk_pop" href="#alzheimer.REF.guerreiro.2013.117">Guerreiro et al 2013</a>, <a class="bk_pop" href="#alzheimer.REF.jonsson.2013.107">Jonsson et al 2013</a>]</div></li><li class="half_rhythm"><div>2 August 2012 (tb) Revision: addition of information about <i>APP</i> mutation p.Ala673Thr</div></li><li class="half_rhythm"><div>30 March 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 July 2008 (cd) Revision: single-nucleotide <a class="def" href="/books/n/gene/glossary/def-item/polymorphism/">polymorphism</a> (SNP) in <i>CALHM1</i> associated with increased risk for late-onset AD.</div></li><li class="half_rhythm"><div>13 June 2007 (tb) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> for <i>APP</i> available on a clinical basis; new <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> identified for late-onset <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> AD</div></li><li class="half_rhythm"><div>9 May 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 February 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 December 2003 (tb) Author revisions</div></li><li class="half_rhythm"><div>12 September 2003 (tb) Revision: clinical testing available for <i>APP</i></div></li><li class="half_rhythm"><div>29 January 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 June 2001 (tb) Author revisions</div></li><li class="half_rhythm"><div>24 September 1999 (tb) Author revisions</div></li><li class="half_rhythm"><div>31 August 1999 (tb) Author revisions</div></li><li class="half_rhythm"><div>23 October 1998 (me) Overview posted live</div></li><li class="half_rhythm"><div>Spring 1996 (tb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1161</span><span class="label">PMID: <a href="/pubmed/20301340" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301340</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/alstrom/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/amish-mcph/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1161&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1161/?report=reader">PubReader</a></li><li><a href="/books/NBK1161/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1161" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1161" style="display:none" title="Cite this Page"><div class="bk_tt">Bird TD. Alzheimer Disease Overview. 1998 Oct 23 [Updated 2018 Dec 20]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1161/pdf/Bookshelf_NBK1161.pdf">PDF version of this page</a> (420K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#alzheimer.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#alzheimer._escape__1_Clinical_Characteri" ref="log$=inpage&amp;link_id=inpage">1. Clinical Characteristics of Alzheimer Disease</a></li><li><a href="#alzheimer._escape__2_Causes_of_Alzheimer" ref="log$=inpage&amp;link_id=inpage">2. Causes of Alzheimer Disease</a></li><li><a href="#alzheimer._escape__3_Evaluation_Strategi" ref="log$=inpage&amp;link_id=inpage">3. Evaluation Strategies to Identify the Genetic Cause of Alzheimer Disease in a Proband</a></li><li><a href="#alzheimer._escape__4_Inform_Genetic_Coun" ref="log$=inpage&amp;link_id=inpage">4. Inform Genetic Counseling of Family Members of an Individual with Alzheimer Disease</a></li><li><a href="#alzheimer.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#alzheimer.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#alzheimer.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5328[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PLAU</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">A2M</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5664[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PSEN2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=348[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">APOE</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4353[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MPO</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5663[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PSEN1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=351[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">APP</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3077[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HFE</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4846[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NOS3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1482490" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1482490" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28350801" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.</a><span class="source">[PLoS Med. 2017]</span><div class="brieflinkpop offscreen_noflow">APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lanoiselée HM, Nicolas G, Wallon D, Rovelet-Lecrux A, Lacour M, Rousseau S, Richard AC, Pasquier F, Rollin-Sillaire A, Martinaud O, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">PLoS Med. 2017 Mar; 14(3):e1002270. Epub 2017 Mar 28.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12925374" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease.</a><span class="source">[Arch Neurol. 2003]</span><div class="brieflinkpop offscreen_noflow">A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ezquerra M, Lleó A, Castellví M, Queralt R, Santacruz P, Pastor P, Molinuevo JL, Blesa R, Oliva R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Arch Neurol. 2003 Aug; 60(8):1149-51. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12552037" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Early onset familial Alzheimer's disease: Mutation frequency in 31 families.</a><span class="source">[Neurology. 2003]</span><div class="brieflinkpop offscreen_noflow">Early onset familial Alzheimer's disease: Mutation frequency in 31 families.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurology. 2003 Jan 28; 60(2):235-9. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/15654674" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Genetic counseling and testing for families with Alzheimer's disease].</a><span class="source">[Neurol Neurochir Pol. 2004]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Genetic counseling and testing for families with Alzheimer's disease].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kowalska A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurol Neurochir Pol. 2004 Nov-Dec; 38(6):495-501. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16538594" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Genes in Alzheimer's disease].</a><span class="source">[Rev Neurol. 2006]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Genes in Alzheimer's disease].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hoenicka J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rev Neurol. 2006 Mar 1-15; 42(5):302-5. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301340" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301340" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041950dd21425a2550b251">Alzheimer Disease Overview - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Alzheimer Disease Overview - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:22:08-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AF2D1E040FC010000000004300198&amp;ncbi_session=CE8AF2D1E04194F1_1072SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1161%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1161&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1161/&amp;ncbi_pagename=Alzheimer Disease Overview - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AF2D1E04194F1_1072SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>